Abatacept Might Be First-Ever Treatment for Rare Immune DeficiencyAbatacept Might Be First-Ever Treatment for Rare Immune Deficiency

Some devastating aspects of common variable immune deficiency are a result of a defect in trafficking of the immune down-regulator CTLA4, which can be overcome by treatment with abatacept. Medscape Medical News
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Family Medicine/Primary Care News Source Type: news

Related Links:

Costs include time needed for research and testing, maintenance and other fees, hardware updates
Source: The Doctors Lounge - Psychiatry - Category: Psychiatry Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nephrology, Neurology, Nursing, Oncology, Ophthalmology, Orthopedics, ENT, Source Type: news
Pediatric Allergy and Immunology, EarlyView.
Source: Pediatric Allergy and Immunology - Category: Allergy & Immunology Authors: Source Type: research
Int Arch Allergy Immunol
Source: International Archives of Allergy and Immunology - Category: Allergy & Immunology Source Type: research
Obsessive hygiene, antibiotics and car exhausts are blamed for hay fever now affecting 20% of Britain ’s populationThis has been the worst month for hay fever for 12 years. Grasses had perfect growing conditions over late April and in May with warm sunshine and showers. That was followed in June by hot dry conditions when the grass flowers matured and shed clouds of pollen on light breezes and up people ’s noses.The strange thing is that hay fever was incredibly rare when it was first reported by John Bostoc, a London doctor, nearly 200 years ago. Yet in those days far more people lived and worked in the countr...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Hay fever Allergies Plants Air pollution Greenhouse gas emissions Environment Science UK news Source Type: news
CONCLUSIONS: This study provides detailed information that facilitates studying CRS and its main phenotypes. However, patient distribution of this study does not necessarily reflect disease distribution in the general population. PMID: 29911211 [PubMed - as supplied by publisher]
Source: Rhinology - Category: ENT & OMF Tags: Rhinology Source Type: research
A team of AIDS researchers in Hong Kong says its new research, tested on mice, indicates a functional cure for HIV, eventually leading to a new antibody that could be used for both prevention and treatment.Reuters Health Information
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Infectious Diseases News Source Type: news
Golden Star Wholesale of Troy, MI 48084 is recalling, AL Reef Dried Apricots Sour, because it may contain undeclared sulfites. People who have an allergy or severe sensitivity to sulfites run the risk of serious or life-threatening allergic reactions if they consume this product.
Source: Food and Drug Administration - Category: Food Science Source Type: news
Conclusions: Overall, the blood and nasal lavage samples showed vastly distinct gene expression profiles and functional gene pathways which reflect their anatomical and functional origins. Evaluating immune gene expression of the nasal mucosa in addition to blood samples may be beneficial in understanding AR pathophysiology and response to allergen challenge.Int Arch Allergy Immunol
Source: International Archives of Allergy and Immunology - Category: Allergy & Immunology Source Type: research
Publication date: November 2018 Source:Microchemical Journal, Volume 142 Author(s): Evelyn Marín-Barroso, Cristian M. Moreira, Germán A. Messina, Franco A. Bertolino, Mara Alderete, Galo J.A.A. Soler-Illia, Julio Raba, Sirley V. Pereira A novel fluorescent paper based immunosensor for the quantification of gliadin content in different food samples was constructed. The device consists of a paper platform modified with amino functionalized mesoporous material. The nanoporous structure and the aminofunctionality increased the anti-gliadin antibodies immobilization capacity of the sensing surface, conferring hig...
Source: Microchemical Journal - Category: Chemistry Source Type: research
Conclusions This study confirms that mepolizumab is an effective and well-tolerated therapy for HES, but suggests that response is more likely in GC-responsive subjects with idiopathic or overlap forms of HES. A primary benefit of treatment is the reduction of comorbidity due to discontinuation or the reduction of conventional HES therapies. Although subjects who completely discontinued GC had the most benefit, high-dose mepolizumab was a safe and effective salvage therapy for severe, treatment-refractory HES.
Source: The Journal of Allergy and Clinical Immunology: In Practice - Category: Allergy & Immunology Source Type: research
More News: Abatacept | Allergy | Allergy & Immunology | Orencia | Primary Care